Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs
4 Jan 2024 - Angle receives 'breakthrough results' from DNA molecular analysis
4 Jan 2024 - Angle gains Berenberg's confidence thanks to Eisai partnership
2 Jan 2024 - Angle locks in $250,000 contract with Eisai
2 Jan 2024 - IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial
2 Jan 2024 - TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing
11 Dec 2023 - IN BRIEF: Angle launches diagnostic kit at cancer symposium
5 Dec 2023 - Angle says build up of revenue slower than hoped; launches test
9 Nov 2023
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs
(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest d...
Angle receives 'breakthrough results' from DNA molecular analysis
(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday...
Angle gains Berenberg's confidence thanks to Eisai partnership
(Alliance News) - Angle PLC has hit a "landmark achievement", says Berenberg, as its pilot study partnership with Eisai Inc may lead to major market e...
Angle locks in $250,000 contract with Eisai
(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumou...
IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial
Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the...
TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
IN BRIEF: Angle launches diagnostic kit at cancer symposium
Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium...
Angle says build up of revenue slower than hoped; launches test
(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed t...
Follow the stocks
